Back to Search
PHILIP WYATT, DO
DO
Internal Medicine Physician
NPI: 1184205221IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
5101027605(MI)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
5151014946(MI)
Education
OTHER
Class of 2021
Research & Publications (20)
Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design.
PMID 18656911·J Med Chem·2008
7-preclinical
Synthesis and chemistry of enantiomerically pure 10,11-dihydrodibenzo[b,f]thiepines.
PMID 16729131·Org Biomol Chem·2006
8-other
2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: Identification, stereochemistry and initial SAR.
PMID 15863320·Bioorg Med Chem Lett·2005
8-other
Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives.
PMID 11992786·Bioorg Med Chem Lett·2002
7-preclinical
Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives.
PMID 11992787·Bioorg Med Chem Lett·2002
7-preclinical
Structure-activity relationship investigations of a potent and selective benzodiazepine oxytocin antagonist.
PMID 11392542·Bioorg Med Chem Lett·2001
7-preclinical
Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.
PMID 11266166·Bioorg Med Chem Lett·2001
8-other
Nonradiative de-excitation mechanisms in long-lived erbium(III) organic compounds ErxY1-x[(p-CF3-C6F4)2PO2]3.
PMID 19422221·J Phys Chem B·2009
8-other
One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening.
PMID 19527033·J Med Chem·2009
7-preclinical
Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity.
PMID 19143567·J Med Chem·2009
7-preclinical
Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase.
PMID 19557802·ChemMedChem·2009
7-preclinical
Fragile X testing in obstetrics and gynaecology in Canada.
PMID 18845054·J Obstet Gynaecol Can·2008
6-review
New molecular techniques for the prenatal detection of chromosomal aneuploidy.
PMID 18644185·J Obstet Gynaecol Can·2008
8-other
Lessons learnt from assembling screening libraries for drug discovery for neglected diseases.
PMID 18064617·ChemMedChem·2008
8-other
Maternal obesity and the risk of placental vascular disease.
PMID 19175965·J Obstet Gynaecol Can·2008
8-other
Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib.
PMID 18633129·Blood·2008
8-other
Developing nonstationary noise estimation for application in edge and corner detection.
PMID 17605382·IEEE Trans Image Process·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6465 MILLENNIUM STE 100
LANSING, MI 48917 - Phone
- (517) 975-3720
Quick Facts
- NPI
- 1184205221
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile